Effect of drug concentration on adsorption of levofloxacin by polyacrylonitrile haemofilters


Autoria(s): Tian, Qi; Gomersall, Charles D.; Wong, April; Leung, Patricia; Choi, Gordon; Joynt, Gavin M.; Tan, Perpetua; Lipman, Jeff
Contribuinte(s)

A. M. Geddes

Data(s)

01/01/2006

Resumo

We studied an in vitro model of continuous venovenous haemofiltration to determine levofloxacin adsorption by polyacrylonitrile (PAN) filters. Four doses of levofloxacin (5, 25, 50 and 100 mg) were used, resulting in circulating concentrations of levofloxacin at 120 min of 3.56 +/- 0.14, 15.84 +/- 2.08, 31.42 +/- 1.95 and 58.23 +/- 1.10 mg/L, respectively. Adsorption at 2 h was 0.65 +/- 0.17, 5.99 +/- 2.49, 12.30 +/- 2.34 and 30.13 +/- 1.32 mg, respectively (P < 0.001). From 2 h to 4 h, increasing the blood pump rate and the ultrafiltration rate had no effect on adsorption. When the concentration was decreased from 3.55 +/- 0.13 mg/L at 4 h to 2.16 +/- 0.11 mg/L at 5 h by addition of lactated Ringer's solution, adsorption decreased from 0.67 +/- 0.16 mg to 0.21 +/- 0.25 mg (P < 0.05). These data show that adsorption of levofloxacin by PAN haemofilters is concentration dependent and reversible in vitro and suggest that adsorption by haemofilters is unlikely to affect levofloxacin pharmacokinetics significantly in vivo. (c) 2006 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Identificador

http://espace.library.uq.edu.au/view/UQ:79945

Idioma(s)

eng

Publicador

Elsevier Science Bv

Palavras-Chave #Renal Replacement Therapy #Adsorption #Quinolones #Kidney Failure #Pharmacokinetics #Infectious Diseases #Microbiology #Pharmacology & Pharmacy #Continuous Venovenous Hemofiltration #Critically Ill Patients/ #Elimination #Failure #Serum #C1 #321009 Intensive Care #730199 Clinical health not specific to particular organs, diseases and conditions #11 Medical and Health Sciences #1115 Pharmacology and Pharmaceutical Sciences
Tipo

Journal Article